%0 Journal Article
%T Inflammatory myofibroblastic tumour of the lung: a reactive lesion or a true neoplasm?
%A David Lawrence
%A Davide Patrini
%A Elaine Borg
%A Lasha Gvinianidze
%A Nikolaos Panagiotopoulos
%A Wen Ling Woo
%J SCIE-indexed Journal
%D 2015
%R 10.3978/j.issn.2072-1439.2015.04.60
%X First described by Brunn in 1937, inflammatory myofibroblastic tumour (IMT) represents an extremely rare type of inflammatory pseudo-tumour that appears most commonly in children and young individuals with a prevalence ranging from 0.04% to 0.7% irrespective of the gender and race of the world population (1,2). There has been an ongoing controversy whether an IMT is a reactive lesion or a true neoplasm (3). This has been revealed in a large number of individual case reports and series with subtle differences in their clinico-pathological findings and the results of the treatment provided. Purpose of the paper is, through a literature review, to identify the clinical approach of this rare tumour highlighting key features and the available management options
%U http://jtd.amegroups.com/article/view/4439/html